MannKind Ownership | Who Owns MannKind?

Overview Forecast RevenueFinancials Chart Transcripts

MannKind Ownership Summary

MannKind is owned by 57.66% institutional investors, 1.53% insiders, and 40.81% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.36% of MNKD shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.95% of its assets in MannKind shares.

MNKD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MannKind	57.66%	1.53%	40.81%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	28.60M	9.36%	$70.07M
Blackrock	22.56M	8.34%	$117.75M
State street	18.68M	6.11%	$45.77M
Vanguard group	17.88M	5.83%	$101.38M
Ubs group	8.26M	2.70%	$20.23M
Geode capital management	7.51M	2.46%	$18.39M
Millennium management	6.39M	2.09%	$15.66M
Frazier life sciences management	5.90M	1.93%	$14.46M
Morgan stanley	5.79M	1.90%	$14.19M
Dimensional fund advisors lp	4.95M	1.62%	$12.13M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tsp capital management group	3.34M	2.00%	$8.19M
180 wealth advisors	4.29M	1.20%	$10.51M
Scopia capital management lp	694.96K	1.17%	$1.70M
1492 capital management	549.78K	0.51%	$1.35M
Frazier life sciences management	5.90M	0.37%	$14.46M
Deltec asset management	428.00K	0.19%	$1.05M
Bruce	195.07K	0.14%	$477.93K
Rubric capital management lp	3.62M	0.09%	$8.87M
Clarivest asset management	164.59K	0.09%	$859.19K
Diadema partners lp	186.60K	0.08%	$457.18K

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	6.39M	0.01%	5.88M
State street	18.68M	0.00%	4.06M
Ubs group	8.26M	0.00%	3.15M
Vanguard fiduciary trust	2.14M	0.00%	2.14M
Two sigma investments, lp	2.90M	0.01%	1.71M

Top Sellers

Holder	Shares	% Assets	Change
Nitorum capital	-	-	-5.33M
Rubric capital management lp	3.62M	0.09%	-3.86M
Citadel advisors	1.19M	0.00%	-2.38M
Avoro capital advisors	2.20M	0.05%	-2.24M
Adage capital partners gp	-	-	-1.89M

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	2.14M	0.00%	2.14M	$5.24M
Point72 asset management	1.25M	0.00%	1.25M	$3.06M
Empowered funds	765.36K	0.01%	765.36K	$1.88M
Woodline partners lp	719.13K	0.01%	719.13K	$1.76M
Centerbook partners lp	430.96K	0.06%	430.96K	$1.06M

Sold Out

Holder	Change
Mather group, llc.	-4.00
Tfc financial management	-6.00
Geowealth management	-9.00
Newbridge financial services group	-10.00
Rialto wealth management	-14.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	251	-4.56%	176,220,437	-2.60%	57	1.66%	128	-4.48%	70	1.45%
Dec 31, 2025	72	-70.12%	32,410,285	-81.24%	10	0.33%	35	-66.98%	15	-80.77%
Sep 30, 2025	85	-64.14%	32,712,871	-80.77%	10	0.34%	37	-63.00%	25	-63.24%
Jun 30, 2025	233	-11.41%	169,987,066	-3.57%	56	1.66%	95	-22.76%	69	-2.82%
Mar 31, 2025	259	2.78%	176,169,093	4.99%	58	1.56%	120	-8.40%	72	38.46%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	12.19M	3.95%	-120.47K
Vanguard Total Stock Mkt Idx Inv	9.15M	2.96%	-
Vanguard US Total Market Shares ETF	8.09M	2.66%	-22.90K
iShares Russell 2000 ETF	7.17M	2.32%	60.44K
Vanguard Institutional Extnd Mkt Idx Tr	3.47M	1.12%	36.43K
Fidelity Select Biotechnology	3.18M	1.03%	997.10K
Fidelity Small Cap Index	2.95M	0.96%	28.61K
SPDR® S&P Biotech ETF	2.87M	0.93%	6.40K
iShares Russell 2000 Growth ETF	2.50M	0.81%	6.45K
iShares Biotechnology ETF	2.20M	0.71%	42.01K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 12, 2026	Binder Steven B.	-	Sell	$55.73K
May 12, 2026	Thomson David	EVP Genl Counsel & Secretary	Sell	$9.98K
Mar 10, 2026	Castagna Michael	Chief Executive Officer	Buy	$259.00K
Jan 08, 2026	Tross Stuart A	Chief People & Workpl Officer	Sell	$297.55K
Dec 17, 2025	Castagna Michael	Chief Executive Officer	Sell	$395.48K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	2
2026 Q1	1	1
2025 Q4	-	5
2025 Q3	-	3
2025 Q2	-	5

MNKD Ownership FAQ

Who Owns MannKind?

MannKind shareholders are primarily institutional investors at 57.66%, followed by 1.53% insiders and 40.81% retail investors. The average institutional ownership in MannKind's industry, Biotech Stocks , is 35.75%, which MannKind exceeds.

Who owns the most shares of MannKind?

MannKind’s largest shareholders are Blackrock funding, inc. /de (28.6M shares, 9.36%), Blackrock (22.56M shares, 8.34%), and State street (18.68M shares, 6.11%). Together, they hold 23.81% of MannKind’s total shares outstanding.

Does Blackrock own MannKind?

Yes, BlackRock owns 8.34% of MannKind, totaling 22.56M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 117.75M$. In the last quarter, BlackRock increased its holdings by 931.32K shares, a 4.31% change.

Who is MannKind’s biggest shareholder by percentage of total assets invested?

Tsp capital management group is MannKind’s biggest shareholder by percentage of total assets invested, with 2.00% of its assets in 3.34M MannKind shares, valued at 8.19M$.

Who is the top mutual fund holder of MannKind shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of MannKind shares, with 3.95% of its total shares outstanding invested in 12.19M MannKind shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools